Results
|
|
1.
|
Cost-effectiveness of Icosapent Ethyl for High-risk Patients With Hypertriglyceridemia Despite Statin Treatment. MedStar authors:
- Dolman, Sarahfaye
- Kolm, Paul
- Weintraub, William S
Year: 2022
Citation: - JAMA Network Open. 5(2):e2148172, 2022 02 01.
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
Medline publication type:
- Journal Article
- Research Support, Non-U.S. Gov't
All authors: - Andrade K, Ballantyne CM, Bellows BK, Bhatt DL, Boden WE, Bress AP, Brinton EA, Derington CG, Dolman S, Jacobson TA, Johnson J, King JB, Kolm P, Miller M, Steg PG, Tajeu GS, Tardif JC, Weintraub WS, Zhang Z
|
|
|
2.
|
The economic burden of hypertriglyceridemia among US adults with diabetes or atherosclerotic cardiovascular disease on statin therapy. MedStar authors:
- Case, Brian C
- Kolm, Paul
- Weintraub, William S
Year: 2019
Citation: - Journal of Clinical Lipidology. 13(5):754-761, 2019 Sep - Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bress AP, Case BC, Fan W, Granowitz CB, Herrick JS, Hull M, Kolm P, Philip S, Toth PP, Weintraub WS, Wong ND
|
|
|
3.
|
Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. MedStar authors:
Year: 2021
Citation: - American Heart Journal. 237:90-103, 2021 07.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Boden W, Budoff M, Chaitman B, Conlon M, Cooper-Dehoff RM, Frayne SM, Handberg EM, Lo MC, Merz CNB, O'Malley P, Pepine CJ, Rogatko A, Shaw LJ, Spertus JA, Villines T, Wei J, Weintraub W
|
